Hogy

Founded in 1961 and based in Tokyo, Japan, Hogy Medical Co. , Ltd. ,d b. a.

Hogy, manufactures medical supplies and devices, provides sterilization, kit assembly, and delivery services to healthcare providers, and continues operations in healthcare safety without structural changes or disclosed parent or subsidiary entities reported. In March 2026, Carlyle Group acquired 18 million shares of Hogy Medical Co. , Ltd. at JPY 6,700 apiece for JPY 126 billion, in a PIPE transaction, as part of a two-step take‑private process.

Hogy Medical Co. , Ltd. specializes in manufacturing high-quality medical and healthcare products designed for both general consumers and healthcare professionals. The company’s core offerings include premium masks that are widely utilized by medical practitioners, sterilization supplies, non-woven surgical products, and a range of re-manufactured single-use medical devices (R-SUD).

Their flagship products, such as the Premium Kit® and specialized surgical supplies, aim to enhance safety and efficiency in medical environments while addressing the increasing demand for personal protective equipment (PPE) in both hospital and home settings. Hogy Medical primarily serves hospitals and healthcare providers, ensuring that their products meet stringent safety and efficacy standards. The company markets its products primarily in Japan, with a growing interest in expanding its reach to other Asian markets. In 2023, Hogy Medical Co.

, Ltd. reported a revenue of USD 288. 49 mn and an EBITDA of USD 75. 87 mn.

The company generates revenue through a combination of direct sales and partnerships with healthcare facilities and distributors, selling medical supplies and equipment directly to hospitals, clinics, and healthcare providers. They also engage in business-to-business (B2B) relationships, supplying products to wholesalers and retailers for broader distribution. Pricing structures for various products are set according to market standards and the demand for specialized medical equipment. As of March 2026, company plans to expand surgical kit offerings, increase sterilization capacity, improve production automation, strengthen hospital integration, and pursue sales through subsidiaries.